[Therapy of advanced neuroblastoma by the protocol of the Welfare Ministry used by the Sawaguchi Group].

Five patients with advanced neuroblastoma were treated with the protocol of the Welfare Ministry used by the Sawaguchi group. This protocol consists of cyclophosphamide (CPM), vincristine (VCR), 4'-O-tetrahydropyranyladriamycin (THP-ADM) and cisplatinum (CDDP). Two patients treated with this protocol as the first therapy obtained partial remission. Two patients who had obtained complete remission before the treatment with this protocol remained in complete remission after the treatment. One patient who had shown poor response to the therapy given before treatment with this protocol also showed poor response to the protocol. The most significant side effect with this protocol was myelosuppression, the severity of which was closely related to the dose of THP-ADM. Damage to the liver, kidney and heart was not very significant. We advocate that patients with advanced neuroblastoma can obtain complete remission with the aid of surgery and radiotherapy, etc., if they are treated with the present protocol as the first therapy.
AuthorsS Shida, H Arioka, Y Hatayama, H Nakadate, Y Hatae, T Takeda
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 15 Issue 3 Pg. 425-9 (Mar 1988) ISSN: 0385-0684 [Print] JAPAN
PMID3348628 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • pirarubicin
  • Cisplatin
  • Adrenal Gland Neoplasms (drug therapy)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Bone Marrow (drug effects)
  • Child, Preschool
  • Cisplatin (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage, analogs & derivatives)
  • Drug Administration Schedule
  • Humans
  • Infant
  • Male
  • Neuroblastoma (drug therapy)
  • Remission Induction
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: